# Red Cell Transfusion Goals in Patients With Acute Leukemias

> **NCT02086773** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 90 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia
- Acute Lymphocytic Leukemia (ALL)
- Acute Myelogenous Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)

## Interventions

- **BIOLOGICAL:** Red blood cell transfusion

## Key facts

- **NCT ID:** NCT02086773
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2019-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02086773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02086773, "Red Cell Transfusion Goals in Patients With Acute Leukemias". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02086773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*